Cargando…

The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patients

Modern advances in technology such as next-generation sequencing and digital PCR make detection of minor circulating cell-free tumor DNA amounts in blood from cancer patients possible. Samples can be obtained minimal-invasively, tested for treatment-determining genetic alterations and are considered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knuever, Jana, Weiss, Jonathan, Persa, Oana-Diana, Kreuzer, Karl, Mauch, Cornelia, Hallek, Michael, Schlaak, Max
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7080785/ https://www.ncbi.nlm.nih.gov/pubmed/32188904 http://dx.doi.org/10.1038/s41598-020-61818-1

Ejemplares similares

Regression of metastatic melanoma by targeting cancer stem cells
por: Schlaak, Max, et al.
Publicado: (2012)

TIGIT(+) NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients
por: Tsakmaklis, Anastasia, et al.
Publicado: (2023)

Successful Treatment of Myasthenia Gravis Following PD-1/CTLA-4 Combination Checkpoint Blockade in a Patient With Metastatic Melanoma
por: Werner, Jan-Michael, et al.
Publicado: (2019)

Oligometastatic disease and visceral resections in advanced malignant melanoma: a propensity-matched analysis
por: Urbanski, Alexander, et al.
Publicado: (2023)

Whole-Body Imaging for the Primary Staging of Melanomas—A Single-Center Retrospective Study
por: Mayer, Kristine E., et al.
Publicado: (2023)

The epidermal polarity protein Par3 is a non–cell autonomous suppressor of malignant melanoma
por: Mescher, Melina, et al.
Publicado: (2017)

A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score
por: Schaefer, Hannah, et al.
Publicado: (2022)

OTHR-14. TREATMENT MONITORING OF IMMUNOTHERAPY AND TARGETED THERAPY USING FET PET IN PATIENTS WITH MELANOMA AND LUNG CANCER BRAIN METASTASES: INITIAL EXPERIENCES
por: Galldiks, Norbert, et al.
Publicado: (2019)

Development of Lymphopenia during Therapy with Immune Checkpoint Inhibitors Is Associated with Poor Outcome in Metastatic Cutaneous Melanoma
por: Tomsitz, Dirk, et al.
Publicado: (2022)

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients
por: Long-Mira, Elodie, et al.
Publicado: (2018)

Clinical determinants of long-term survival in metastatic uveal melanoma
por: Koch, Elias A. T., et al.
Publicado: (2021)

Successful Treatment of a Panniculitis-Like Primary Cutaneous T-Cell Lymphoma of the α/β Type with Bexarotene
por: Zhang, X., et al.
Publicado: (2012)

Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma
por: Joshi, Powrnima, et al.
Publicado: (2014)

No Evidence for Role of Cutavirus in Malignant Melanoma
por: Wieland, Ulrike, et al.
Publicado: (2019)

Fibroblast MMP14-Dependent Collagen Processing Is Necessary for Melanoma Growth
por: Pach, Elke, et al.
Publicado: (2021)

Metastatic Melanoma With Leptomeningeal Disease
por: Marinova, Amanda M., et al.
Publicado: (2021)

The Role of Immune Checkpoint Blockade in Uveal Melanoma
por: Wessely, Anja, et al.
Publicado: (2020)

Anaplastic pleomorphic xanthoastrocytoma with epithelioid morphology misdiagnosed and treated as melanoma
por: Dorostkar, Mario M, et al.
Publicado: (2022)

Durable Response to Vemurafenib and Cobimetinib for the Treatment of BRAF-Mutated Metastatic Melanoma in Routine Clinical Practice
por: Álamo, Mª del Carmen, et al.
Publicado: (2021)

Pre-Diagnostic Circulating Vitamin D and Risk of Melanoma in Men
por: Major, Jacqueline M., et al.
Publicado: (2012)

Tebentafusp in Patients with Metastatic Uveal Melanoma: A Real-Life Retrospective Multicenter Study
por: Tomsitz, Dirk, et al.
Publicado: (2023)

Choroidal melanoma metastatizing to the biliary system: A diagnostic dilemma
por: Agarwal, Samir R., et al.
Publicado: (2009)

Diagnostic Delays in Metastatic Amelanotic Melanoma Presenting as Breast Pain
por: Do, Tiffanie, et al.
Publicado: (2020)

Pulmonary metastatic melanoma: current state of diagnostic imaging and treatments
por: Zhang, Kermit S, et al.
Publicado: (2021)

Tebentafusp in combination with durvalumab and/or tremelimumab in patients with metastatic cutaneous melanoma: a phase 1 study
por: Hamid, Omid, et al.
Publicado: (2023)

Quantitative assessment of BRAF V600 mutant circulating cell-free tumor DNA as a tool for therapeutic monitoring in metastatic melanoma patients treated with BRAF/MEK inhibitors
por: Schreuer, Max, et al.
Publicado: (2016)

Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma
por: Anand, Kartik, et al.
Publicado: (2019)

Analysis of the Whole-Exome Sequencing of Tumor and Circulating Tumor DNA in Metastatic Melanoma
por: Diefenbach, Russell J., et al.
Publicado: (2019)

Correlating Radiomic Features of Heterogeneity on CT with Circulating Tumor DNA in Metastatic Melanoma
por: Gill, Andrew B., et al.
Publicado: (2020)

Ultrasensitive detection of BRAF mutations in circulating tumor DNA of non-metastatic melanoma
por: Gouda, M.A., et al.
Publicado: (2021)

Circulating Neoplastic-Immune Hybrid Cells Predict Metastatic Progression in Uveal Melanoma
por: Parappilly, Michael S., et al.
Publicado: (2022)

Expression and function of the Kallikrein-related peptidase 6 in the human melanoma microenvironment
por: Krenzer, Stefanie, et al.
Publicado: (2011)

Combined immune checkpoint blockade for metastatic uveal melanoma: a retrospective, multi-center study
por: Heppt, Markus V., et al.
Publicado: (2019)

Assessment of Different Circulating Tumor Cell Platforms for Uveal Melanoma: Potential Impact for Future Routine Clinical Practice
por: Martel, Arnaud, et al.
Publicado: (2023)

Extracellular Matrix Remodeling by Fibroblast-MMP14 Regulates Melanoma Growth
por: Pach, Elke, et al.
Publicado: (2021)

Diagnostic challenge for ovarian malignant melanoma in premenopausal women: Primary or metastatic?
por: Sbitti, Yassir, et al.
Publicado: (2011)

Capsular nevus versus metastatic malignant melanoma – a diagnostic dilemma
por: Davis, Justin, et al.
Publicado: (2016)

Diagnostic Aqueous Humor Proteome Predicts Metastatic Potential in Uveal Melanoma
por: Peng, Chen-Ching, et al.
Publicado: (2023)

Minimal Residual Disease Assessment in CLL: Ready for Use in Clinical Routine?
por: Fürstenau, Moritz, et al.
Publicado: (2019)

Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients
por: McEvoy, Ashleigh C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c7hcrfskuvcg486q8c4rkvn68e